Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells

BMC Med Genomics. 2022 Jul 8;15(1):155. doi: 10.1186/s12920-022-01309-6.
No abstract available

Publication types

  • Published Erratum